Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nabilone for Agitation in Frontotemporal Dementia
NCT05742698Phase 2Terminated
- Start
- Mar 2023
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nabilone in frontotemporal dementia (FTD). Started Mar 2023; status: terminated.
02
Drugs
nabilone
03
Conditions
frontotemporal dementia (FTD)
Beyond the preview
Go deeper on NCT05742698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05742698.